BridgeMD
New treatment option for Hypercholesterolemia
Official title A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
ClinicalTrials.gov ID: NCT07477704
What this study is testing
What is Alirocumab?
Alirocumab is an investigational medicine, given as an once-weekly, being studied as a potential treatment for hypercholesterolemia.
Also referred to as Praluent®, REGN727.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is researching an experimental drug called alirocumab, referred to as "study drug". In the United States, alirocumab is approved for the treatment of hypercholesterolemia (high blood cholesterol levels).
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- 1\. Participant has elevated LDL-C level, as defined in the protocol
You likely can't join if
- Participant plans to initiate or change dose of lipid-lowering therapy
- Use of any PCSK9 inhibitors NOTE: Other Protocol-Defined Inclusion/Exclusion Criteria Apply
The study team makes the final eligibility decision.
Where it's taking place
- Anaheim, California, United States
- Los Alamitos, California, United States
- Walnut Creek, California, United States
- Clearwater, Florida, United States
- Fort Myers, Florida, United States
- Sunrise, Florida, United States
- The Villages, Florida, United States
- Gainesville, Georgia, United States
- Lawrenceville, Georgia, United States
- Honolulu, Hawaii, United States
- Louisville, Kentucky, United States
- Marrero, Louisiana, United States
- Butte, Montana, United States
- Omaha, Nebraska, United States
- Las Vegas, Nevada, United States
- Durham, North Carolina, United States
- Columbus, Ohio, United States
- Norman, Oklahoma, United States
- Oklahoma City, Oklahoma, United States
- Medford, Oregon, United States
+ 9 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Anaheim, California, United States; Los Alamitos, California, United States; Walnut Creek, California, United States; Clearwater, Florida, United States; Fort Myers, Florida, United States; Sunrise, Florida, United States and 23 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.